Lilly: Tax reforms would release $150m to further support US manufacturing
Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs